Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group Study

被引：55
|
作者：
Shepherd, FA
Johnston, MR
Payne, D
Burkes, R
Deslauriers, J
Cormier, Y
de Bedoya, LD
Ottaway, J
James, K
Zee, B
机构：
[1] Univ Toronto, Interdept Div Oncol, Toronto, ON, Canada
[2] Hop Laval, St Foy, PQ, Canada
[3] Univ Laval, St Foy, PQ G1K 7P4, Canada
[4] Natl Canc Inst, Canada Clin Trials Grp, Kingston, ON, Canada
[5] Queens Univ, Kingston, ON, Canada
来源：
BRITISH JOURNAL OF CANCER | 1998年 / 78卷 / 05期
关键词：
induction chemotherapy; combined-modality therapy; non-small-cell lung cancer;
D O I：
10.1038/bjc.1998.560
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Thirty-one patients with stage IIIA (N2) non-small-cell lung cancer were randomized to receive radiotherapy alone or chemotherapy with cisplatin and vinblastine followed by surgery. Response rates to induction chemotherapy and radiotherapy were 50% and 53.3% respectively. Complete surgical resection was possible for 62.5% of patients. Median survival times were 16.2 and 18.7 months for radiotherapy alone and chemotherapy-surgery respectively (P = Ns), with no long-term improvement in survival seen with combined-modality treatment.
引用
收藏
页码：683 / 685
页数：3
相关论文
共 50 条
  • [31] Randomized controlled trial of neoadjuvant chemotherapy with cisplatin and vinorelbine in patients with stage IIIA non-small cell lung cancer in China
    Li, Jian
    Yu, Li-Chao
    Chen, Ping
    Shi, Sheng-Bing
    Dai, Chun-Hua
    Wu, Jian-Rong
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2009, 5 (02) : 87 - 94
  • [32] Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis
    Foster, Corey C.
    Rusthoven, Chad G.
    Sher, David J.
    Feldman, Lawrence
    Pasquinelli, Mary
    Spiotto, Michael T.
    Koshy, Matthew
    LUNG CANCER, 2019, 130 : 162 - 168
  • [33] New Radiotherapy and Chemoradiotherapy Approaches for Non-Small-Cell Lung Cancer
    Salama, Joseph K.
    Vokes, Everett E.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (08) : 1029 - 1038
  • [34] Management of stage IIIA non-small cell lung cancer (NSCLC) role of the chemotherapy
    Baudoux, Nathalie
    Friedlaender, Alex
    Addeo, Alfredo
    CURRENT CHALLENGES IN THORACIC SURGERY, 2022, 4
  • [35] Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study
    Zeng, Wan-Qin
    Feng, Wen
    Xie, Li
    Zhang, Chen-Chen
    Yu, Wen
    Cai, Xu-Wei
    Fu, Xiao-Long
    LUNG, 2019, 197 (06) : 741 - 751
  • [36] Clinical Trials Integrating Immunotherapy and Radiation for Non-Small-Cell Lung Cancer
    Daly, Megan E.
    Monjazeb, Arta M.
    Kelly, Karen
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (12) : 1685 - 1693
  • [37] Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study
    Wan-Qin Zeng
    Wen Feng
    Li Xie
    Chen-Chen Zhang
    Wen Yu
    Xu-Wei Cai
    Xiao-Long Fu
    Lung, 2019, 197 : 741 - 751
  • [38] Outcomes of accelerated hypofractionated radiotherapy in stage I non-small-cell lung cancer
    Yung, T.
    Giuliani, M. E.
    Le, L. W.
    Sun, A.
    Cho, B. C. J.
    Bezjak, A.
    Brade, A.
    Hope, A. J.
    CURRENT ONCOLOGY, 2012, 19 (04) : E264 - E269
  • [39] Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
    Roth, JA
    Atkinson, EN
    Fossella, F
    Komaki, R
    Ryan, MB
    Putnam, JB
    Lee, JS
    Dhingra, H
    De Caro, L
    Chasen, M
    Hong, WK
    LUNG CANCER, 1998, 21 (01) : 1 - 6
  • [40] Induction or concomitant chemotherapy and radiotherapy for non-small-cell lung cancer: Myth or reality
    VanHoutte, P
    ANNALS OF ONCOLOGY, 1995, 6 : 37 - 40
12345